A Phase II of AT-101 in Combination with Docetaxel in Patients with Recurrent, Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2012
At a glance
- Drugs AT 101 (Primary) ; Docetaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 10 Feb 2012 New trial record